Patent №
US 6,375,978
Granted
2002-04-23
Filed 1998
Owner
INTARCIA THERAPEUTICS, INC.
+1 more
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09213213
This invention provides rate controlling membranes for controlled drug delivery devices that are stable over time and exhibit more predictable and consistent membrane functionality. According to another aspect, the membranes have enhanced permeability. According to the invention, the rate controlling membrane of a controlled drug delivery device is subjected to a pre-treatment annealing process wherein it is subjected to an elevated temperature for a predetermined time period and subsequently cooled to ambient conditions before incorporation into a controlled drug delivery device.
AI classification
Ownership
INTARCIA THERAPEUTICS, INC.
assignment · 202520143
ALZA CORPORATION
assignment · 225460223
Assignors
KLEINER, LOTHAR W., GALE, ROBERT M., BERGGREN, RANDALL G., TONG, GILBERT T., CHEN, GUOHUA, DIONNE, KEITH E., HOUSTON, PAUL R.
On an employer assignment, the assignors are typically the inventors.